POLARAMINE REPETABS 6MG DIN 00176893
Status: Cancelled Post Market
Holder: SCHERING-PLOUGH CANADA INC
Molecule: DEXCHLORPHENIRAMINE MALEATE
Health Canada record
| Active ingredient(s) | DEXCHLORPHENIRAMINE MALEATE 6 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | R06AB02 DEXCHLORPHENIRAMINE |
| Original market date | 31-Dec-1958 |
| Current status date | 02-Dec-1997 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DEXCHLORPHENIRAMINE MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00028207 | POLARAMINE TAB 2MG | SCHERING-PLOUGH CANADA INC | Tablet | DEXCHLORPHENIRAMINE MALEATE 2 MG | Cancelled Post Market |
International API supply for DEXCHLORPHENIRAMINE MALEATE
1 valid EDQM Certificates of Suitability from 1 holders. 3 active FDA Drug Master Files.
Request a quote for POLARAMINE REPETABS 6MG